Marianna Mancini - Jan 15, 2022 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Chief Operating Officer
Signature
/s/Michael Morneau, as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Jan 15, 2022
Transactions value $
-$3,506
Form type
4
Date filed
2/11/2022, 05:34 PM
Previous filing
Jan 5, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Tax liability -$3.51K -827 -0.35% $4.24 239K Jan 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.